183 related articles for article (PubMed ID: 1355923)
1. Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.
Krystal JH; McDougle CJ; Woods SW; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1992; 108(3):313-9. PubMed ID: 1355923
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.
McDougle CJ; Krystal JH; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1995 Mar; 118(2):127-35. PubMed ID: 7617798
[TBL] [Abstract][Full Text] [Related]
3. Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.
Charney DS; Breier A; Jatlow PI; Heninger GR
Psychopharmacology (Berl); 1986; 88(2):133-40. PubMed ID: 3081923
[TBL] [Abstract][Full Text] [Related]
4. Effects of the alpha 2-antagonist idazoxan on monoaminergic parameters measured in the cerebrospinal fluid of rabbits.
Dillen L; Claeys M; De Potter WP
Eur J Pharmacol; 1987 May; 137(1):33-40. PubMed ID: 2440704
[TBL] [Abstract][Full Text] [Related]
5. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
Charney DS; Woods SW; Goodman WK; Heninger GR
Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
[TBL] [Abstract][Full Text] [Related]
6. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
Doxey JC; Roach AG; Strachan DA; Virdee NK
Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
8. Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice.
Venault P; Jacquot F; Save E; Sara S; Chapouthier G
Life Sci; 1993; 52(7):639-45. PubMed ID: 8094225
[TBL] [Abstract][Full Text] [Related]
9. Alpha 2-adrenoceptor antagonists and male sexual behavior: I. Mating behavior.
Smith ER; Lee RL; Schnur SL; Davidson JM
Physiol Behav; 1987; 41(1):7-14. PubMed ID: 2891151
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
[TBL] [Abstract][Full Text] [Related]
11. The alpha-2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the Vogel lick-shock conflict paradigm following intravenous administration.
La Marca S; Dunn RW
Life Sci; 1994; 54(10):PL179-84. PubMed ID: 7906377
[TBL] [Abstract][Full Text] [Related]
12. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
Charney DS; Heninger GR; Breier A
Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
[TBL] [Abstract][Full Text] [Related]
13. Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers.
Galitzky J; Taouis M; Berlan M; Rivière D; Garrigues M; Lafontan M
Eur J Clin Invest; 1988 Dec; 18(6):587-94. PubMed ID: 2906290
[TBL] [Abstract][Full Text] [Related]
14. Effects of yohimbine and idazoxan on motor behaviors in male rats.
Bowes MP; Peters RH; Kernan WJ; Hopper DL
Pharmacol Biochem Behav; 1992 Apr; 41(4):707-13. PubMed ID: 1350682
[TBL] [Abstract][Full Text] [Related]
15. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD.
Rasmusson AM; Hauger RL; Morgan CA; Bremner JD; Charney DS; Southwick SM
Biol Psychiatry; 2000 Mar; 47(6):526-39. PubMed ID: 10715359
[TBL] [Abstract][Full Text] [Related]
16. Alpha-2-adrenoceptor control of cortisol and ACTH in normal volunteers: preliminary open trial of the effects of acute and chronic idazoxan.
Glue P; Wilson S; Campling GM; Knightly M; Franklin M; Cowen PJ; Nutt DJ
Psychoneuroendocrinology; 1992; 17(2-3):261-6. PubMed ID: 1359600
[TBL] [Abstract][Full Text] [Related]
17. Effects of yohimbine in obsessive compulsive disorder.
Rasmussen SA; Goodman WK; Woods SW; Heninger GR; Charney DS
Psychopharmacology (Berl); 1987; 93(3):308-13. PubMed ID: 2829264
[TBL] [Abstract][Full Text] [Related]
18. [The effect of yohimbine and idazoxan on the systemic and regional hemodynamics of waking rats].
Ivashev MN; Medvedev OS; Giulumian AD
Farmakol Toksikol; 1991; 54(5):20-2. PubMed ID: 1686868
[TBL] [Abstract][Full Text] [Related]
19. The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
Elliott HL; Jones CR; Vincent J; Lawrie CB; Reid JL
Clin Pharmacol Ther; 1984 Aug; 36(2):190-6. PubMed ID: 6146423
[TBL] [Abstract][Full Text] [Related]
20. Effects of tryptophan depletion on responses to yohimbine in healthy human subjects.
Goddard AW; Charney DS; Germine M; Woods SW; Heninger GR; Krystal JH; Goodman WK; Price LH
Biol Psychiatry; 1995 Jul; 38(2):74-85. PubMed ID: 7578653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
